The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India.
Abraham G, Noronha V, Rajappa S, Agarwal A, Batra U, Somani N, Raja T, Patil S, Kaushal AM, Joshi A, Radhakrishnan V, Singh N, Babu G, Tewani R, Baghmar S, Dodagoudar C, Ananthakrishnan R, Haragadde Poppareddy S, Sharma V, Menon N, M Patil V, Joshi A, Gupta S, Prabhash K, Bajpai J.
Abraham G, et al. Among authors: rajappa s.
Int J Cancer. 2022 Mar 15;150(6):1045-1052. doi: 10.1002/ijc.33868. Epub 2021 Nov 25.
Int J Cancer. 2022.
PMID: 34751432